Virios Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-Allotment Option Dec 21, 2020
ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option Dec 18, 2020
cbdMD, Inc. Announces Closing of $17,250,000 Underwritten Public Offering of Its 8.0% Series A Cumulative Convertible Preferred Stock Dec 11, 2020
